Imaging-based thrombolysis trial in acute ischemic stroke-II (ITAIS-II)

International Journal of Stroke

Volumn 4, Issue 1, 2009, Pages 49-53

  Wang, Yilong ^a   Liao, Xiaoling ^a   Zhao, Xingquan ^a   Wang, Chunxue ^a   Liu, Liping ^a   Zhou, Yong ^a   Wang, Chunjuan ^a   Xue, Jing ^a   Gao, Peiyi ^a   Dong, Kehui ^a   Ji, Xunming ^b   Wang, Yong Jun ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Clinical protocols; Controlled clinical trial; Ischemic stroke; Multiparametric CT; rtPA; Thrombolysis

Indexed keywords

ALTEPLASE;

ARTICLE; BRAIN HEMORRHAGE; BRAIN PERFUSION; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FIBRINOLYTIC THERAPY; HUMAN; INTERVENTION STUDY; INTERVENTIONAL RADIOLOGY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT SELECTION; PRIORITY JOURNAL; SAFETY; SINGLE BLIND PROCEDURE;

FIBRINOLYTIC AGENTS; HUMANS; RESEARCH DESIGN; STROKE; THROMBOLYTIC THERAPY; TIME; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED;

EID: 60549111231     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2009.00245.x     Document Type: Article

References (14)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for AIS. N Engl J Med 1995; 333:1581-7.
2. Wahlgren N, Ahmed N, Davalos A et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): An observational study. Lancet 2007; 369:275-82.
3. Hacke W, Donnan G, Fieschi C et al. Association of outcome with early stroke treatment: Pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363:768-74.
4. Schellinger PD, Thomalla G, Fiehler J et al. MRI-based and CT-based thrombolytic therapy in acute stroke within and beyond established time windows: An analysis of 1210 patients. Stroke 2007; 38:2640-5.
5. Rother J: Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke <6 hours. Stroke 2002; 33:2438-45.
6. Davis SM, Donnan GA for the EPITHET investigators et al. Effects of alteplase beyond 3h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): A placebo-controlled randomized trial. Lancet Neurol 2008; 7:299-309.
7. Hacke W, Albers G, Al-Rawi Y et al. The Desmoteplase in AIS Trial (DIAS): A phase II MRI-Based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005; 36:66-73.
8. ECASS 3: The European Cooperative Acute Stroke Study. Available at http://www.ecass3.com/ (accessed February 2, 2008).
9. Parsons MW, Pepper EM, Chan V et al. Perfusion computed tomography: prediction of final infarct extent and stroke outcome. Ann Neurol 2005; 58:672-9.
10. Schellinger PD, Fiebach JB, Jansen O et al. Stroke magnetic resonance imaging within 6 hours after onset of hyperacute cerebral ischemia. Ann Neurol 2001; 49:460-9.
11. Wintermark M, Meuli R, Browaeys P et al. Comparison of CT perfusion and angiography and MRI in selecting stroke patients for acute treatment. Neurology 2007; 68:694-7.
12. Kohrmann M, Juttler E, Fiebach JB et al. MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: A cohort study. Lancet Neurol 2006; 5:661-7.
13. Lin Y, Gao PY: Personal computer aided cerebral perfusion imaging with dynamic CT. Chin Med J 2004; 117:471-3.
14. Mayer TE, Hamann GF, Baranczyk J et al. Dynamic CT perfusion imaging of acute stroke. AJNR 2000; 21: 1441-9.